GLP-1 agonists like Wegovy, Ozempic, and Mounjaro, which are used to treat type 2 diabetes and obesity, have been growing in popularity so much so that in December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss
For patients who were receiving Trulicity for its cardiovascular risk reduction benefits (as demonstrated in the REWIND trial for adults with type 2 diabetes at high cardiovascular risk), discontinuation means this protection may be lost
Handling before injection Remove the vial from the refrigerator 15 to 30 minutes before your injection
Do I need supplements with Retatrutide
A person may perceive appetite or digestive changes early, but this does not prove that meaningful fat loss has occurred
Obesity is one of the most serious health issues facing the nation and is associated with many health conditions, ranging from cardiovascular diseases to cancers, so effective medications to help people control their weight could have substantial health benefits